Amgen Inc. (AMGN) — Stock Price, Chart & Analysis
Amgen Inc. (AMGN) is a Healthcare stock currently trading at $100, up 0.00% on the day. It carries a market capitalization of $222.32B and a trailing P/E ratio of 25.12. Over the past 52 weeks, AMGN has traded between $269.77 and $418.40. Amgen Inc. pays a dividend yielding 2.5%. View the live AMGN chart, technical opinion, analyst ratings, fundamentals and latest news below.
Amgen Inc. (AMGN) key data
| Price | $100 |
| Change (today) | +0.00% |
| Previous close | $100 |
| Market cap | $222.32B |
| P/E ratio (TTM) | 25.12 |
| EPS (TTM) | $16.36 |
| Dividend yield | 2.5% |
| 52-week high | $418.40 |
| 52-week low | $269.77 |
| Beta | 0.41 |
| Avg. volume | 2.73M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
Frequently asked questions about Amgen Inc. (AMGN)
How much does one share of Amgen Inc. cost?
As of the latest update, one share of Amgen Inc. (AMGN) trades at $100 (+0.00% today).
What is Amgen Inc.'s market cap?
Amgen Inc. has a market capitalization of approximately $222.32B.
What is Amgen Inc.'s P/E ratio?
Amgen Inc. has a trailing price-to-earnings (P/E) ratio of 25.12.
What is Amgen Inc.'s earnings per share (EPS)?
Amgen Inc.'s trailing twelve-month EPS is $16.36.
Does Amgen Inc. pay a dividend?
Yes — Amgen Inc. pays a dividend with a yield of 2.5% ($10.08 per share annually).
What is Amgen Inc.'s 52-week trading range?
Over the past year, AMGN has traded between $269.77 and $418.40.
What is the analyst price target for Amgen Inc.?
The mean analyst price target for Amgen Inc. is $374.69. This is informational only and not investment advice.
Latest Amgen Inc. (AMGN) news
- How a 52-Year-Old Can Turn $425,000 Into a Monthly Paycheck Machine by 62News · Aug 8, 2026
- The 4% Rule vs. a Dividend Paycheck: Which Makes $1.25 Million Last Longer?News · Aug 7, 2026
- Replimune Wins FDA Skin Cancer Drug Approval on Third Try. Why the Stock Is Tumbling.News · Aug 7, 2026
- The Two Divergent Paths Priced Into Eli Lilly StockNews · Aug 7, 2026
- Company News for Aug 6, 2026News · Aug 6, 2026
- Amgen Stock Climbs as Drug Growth Outruns Obesity SetbackNews · Aug 5, 2026
Headlines via Yahoo Finance and publishers — click through to read each story at its source.
Loading the live AMGN dashboard…